AURUM PHARMACEUTICALS LIMITED

Company number 02581060

Date	Type	Description	View / Download
10 Oct 2019	AA	Accounts for a dormant company made up to 31 December 2018	(6 pages)
13 Mar 2019	TM01	Termination of appointment of Roseline Georgette Joannesse as a director on 11 March 2019	(1 page)
13 Mar 2019	TM01	Termination of appointment of Michael Christopher James Harris as a director on 1 January 2019	(1 page)
13 Mar 2019	AP01	Appointment of Emmanuel Schmidt as a director on 11 March 2019	(2 pages)
13 Mar 2019	AP01	Appointment of Bertrand Deluard as a director on 11 March 2019	(2 pages)
13 Feb 2019	CS01	Confirmation statement made on 31 January 2019 with no updates	(3 pages)
13 Feb 2019	CH01	Director's details changed for Mr Philip Edward Parry on 1 January 2019	(2 pages)
24 Oct 2018	AA	Accounts for a dormant company made up to 31 December 2017	(6 pages)
15 Mar 2018	CS01	Confirmation statement made on 31 January 2018 with no updates	(3 pages)
29 Aug 2017	AA01	Current accounting period extended from 30 June 2017 to 31 December 2017	(3 pages)
24 Aug 2017	RESOLUTIONS	Resolutions RES13 ‐ Change of accounting ref date/company busniess 09/08/2017	(4 pages)
07 Mar 2017	TM01	Termination of appointment of Jason Grover as a director on 28 February 2017	(1 page)
07 Mar 2017	AP01	Appointment of Roseline Georgette Joannesse as a director on 28 February 2017	(2 pages)
07 Mar 2017	MR04	Satisfaction of charge 6 in full	(1 page)
07 Mar 2017	MR04	Satisfaction of charge 025810600007 in full	(1 page)
01 Feb 2017	CS01	Confirmation statement made on 31 January 2017 with updates	(5 pages)
11 Oct 2016	AA	Accounts for a dormant company made up to 30 June 2016	(8 pages)
09 Feb 2016	AR01	Annual return made up to 31 January 2016 with full list of shareholders Statement of capital on 2016-02-09 GBP 100	(5 pages)
09 Feb 2016	CH01	Director's details changed for Mr Jason Grover on 5 February 2016	(2 pages)
22 Jan 2016	AA	Accounts for a dormant company made up to 30 June 2015	(7 pages)
21 Jul 2015	MR01	Registration of charge 025810600007, created on 17 July 2015	(73 pages)
12 Mar 2015	CH01	Director's details changed for Mr Philip Edward Parry on 11 March 2015	(2 pages)
09 Feb 2015	AR01	Annual return made up to 31 January 2015 with full list of shareholders Statement of capital on 2015-02-09 GBP 100	(5 pages)
09 Feb 2015	AD03	Register(s) moved to registered inspection location C/O Martindale Pharma Building a2 Glory Park Avenue Wooburn Green High Wycombe Buckinghamshire HP10 0DF	(1 page)
09 Feb 2015	AD02	Register inspection address has been changed to C/O Martindale Pharma Building a2 Glory Park Avenue Wooburn Green High Wycombe Buckinghamshire HP10 0DF	(1 page)

Previous

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9

Next